Insigneo Advisory Services LLC Buys 22 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Insigneo Advisory Services LLC grew its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,568 shares of the biotechnology company’s stock after buying an additional 22 shares during the quarter. Insigneo Advisory Services LLC’s holdings in Axon Enterprise were worth $627,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Westfield Capital Management Co. LP grew its position in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after acquiring an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC increased its stake in shares of Axon Enterprise by 13.9% in the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after buying an additional 83,265 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after buying an additional 9,090 shares during the last quarter. 1832 Asset Management L.P. boosted its position in Axon Enterprise by 44.0% during the 2nd quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after buying an additional 114,800 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its holdings in Axon Enterprise by 13.9% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company’s stock worth $108,496,000 after acquiring an additional 45,049 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

AXON has been the topic of a number of recent research reports. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. JMP Securities upped their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Northland Securities increased their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Finally, Robert W. Baird boosted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $488.67.

Axon Enterprise Stock Down 0.3 %

Axon Enterprise stock opened at $687.69 on Friday. The firm has a market capitalization of $52.44 billion, a price-to-earnings ratio of 177.70, a price-to-earnings-growth ratio of 15.13 and a beta of 1.01. The firm’s fifty day moving average price is $516.24 and its two-hundred day moving average price is $393.00. Axon Enterprise, Inc. has a 1-year low of $232.78 and a 1-year high of $698.67. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Insider Buying and Selling

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Patrick W. Smith sold 47,314 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $400.07, for a total value of $18,928,911.98. Following the completion of the transaction, the chief executive officer now owns 2,983,802 shares in the company, valued at $1,193,729,666.14. This represents a 1.56 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 137,921 shares of company stock worth $63,093,907 in the last quarter. Insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.